Rimma Driscoll - May 8, 2025 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
/s/ Jereme M. Sylvain, as Attorney-in-Fact for Rimma Driscoll
Stock symbol
DXCM
Transactions as of
May 8, 2025
Transactions value $
$0
Form type
4
Date filed
5/12/2025, 04:15 PM
Previous filing
Apr 7, 2025
Next filing
Jul 15, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Driscoll Rimma Director 6340 SEQUENCE DRIVE, SAN DIEGO /s/ Jereme M. Sylvain, as Attorney-in-Fact for Rimma Driscoll 2025-05-12 0001952575

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Award $0 +5.07K +76.42% $0.00 11.7K May 8, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSU Award was granted on May 8, 2025 and 100% of the RSU Award will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2 Included in this number are 7,746 unvested restricted stock units, 2,672 of which were granted on August 24, 2023 and shall vest through August 24, 2026 and 5,074 of which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.